191 related articles for article (PubMed ID: 7939781)
1. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
Mariani G; Scheibel E; Nogao T; Kasper CK; Ewing NP; Mauser-Bunschoten E; Ghirardini A; Bellocco R; Brackman HH
Semin Hematol; 1994 Apr; 31(2 Suppl 4):62-4. PubMed ID: 7939781
[No Abstract] [Full Text] [Related]
2. Inhibitors of factor VIII: detection and treatment.
Brettler DB
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to factor VIII in hemophilia A patients.
Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
[TBL] [Abstract][Full Text] [Related]
4. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
White GC; Greenwood R; Escobar M; Frelinger JA
Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
[TBL] [Abstract][Full Text] [Related]
5. [Hemophilia A with factor VIII inhibitor].
Shima M
Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
[No Abstract] [Full Text] [Related]
6. The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.
DiMichele D; Kroner B;
Haematologica; 2000 Oct; 85(10 Suppl):40-2; discussion 42-4. PubMed ID: 11187869
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
Mariani G; Kroner B;
Haematologica; 2001 Nov; 86(11):1186-93. PubMed ID: 11694405
[TBL] [Abstract][Full Text] [Related]
8. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors.
DiMichele DM; Kroner BL;
Thromb Haemost; 2002 Jan; 87(1):52-7. PubMed ID: 11848456
[TBL] [Abstract][Full Text] [Related]
9. Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.
Mariani G; Ghirardini A; Bellocco R
Thromb Haemost; 1994 Jul; 72(1):155-8. PubMed ID: 7974364
[TBL] [Abstract][Full Text] [Related]
10. The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy.
Dimichele D
Haemophilia; 2009 Jan; 15(1):320-8. PubMed ID: 18976249
[TBL] [Abstract][Full Text] [Related]
11. Induction of immune tolerance, the future of the Registry.
Ewing NP
Vox Sang; 1996; 70 Suppl 1():47-51. PubMed ID: 8869469
[TBL] [Abstract][Full Text] [Related]
12. Suggestions for the management of factor VIII inhibitors.
Rubinger M; Rivard GE; Teitel J; Walker H;
Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
[No Abstract] [Full Text] [Related]
13. Hemophilia.
Mariani G; Kroner BL; Brackmann HH
N Engl J Med; 2001 Oct; 345(14):1066; author reply 1067. PubMed ID: 11586969
[No Abstract] [Full Text] [Related]
14. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
[No Abstract] [Full Text] [Related]
15. Factor VIII inhibitor treatment. Immune tolerance.
Nilsson IM
Semin Hematol; 1994 Apr; 31(2 Suppl 4):44-8. PubMed ID: 7939775
[No Abstract] [Full Text] [Related]
16. [Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].
Wu RH; Wei QQ
Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):631-4. PubMed ID: 24225299
[No Abstract] [Full Text] [Related]
17. Immune tolerance to Factor VIII: the international registry data.
Mariani G; Hilgartner M; Thompson AR; Tusell J; Manco-Johnson M; Ghirardini A; Bellocco R; Brackmann HH
Adv Exp Med Biol; 1995; 386():201-8. PubMed ID: 8851029
[No Abstract] [Full Text] [Related]
18. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
19. Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.
Smith MP; Spence KJ; Waters EL; Beresford-Webb R; Mitchell MJ; Cuttler J; Alhaq A; Brown SA; Savidge GF
Thromb Haemost; 1999 Jan; 81(1):35-8. PubMed ID: 9974371
[TBL] [Abstract][Full Text] [Related]
20. [Improvement in anti-hemophilic preparations and its problems. 3. Treatment of hemophilia patients with inhibitors; induction of immune tolerance by a low or intermediate dose regimen].
Iizuka A
Rinsho Ketsueki; 1988 May; 29(5):640-8. PubMed ID: 3145995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
